Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pineda

Showing results (371-380 of 395) with videos related to

Pageof 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Oncogene|March 26, 2014
A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasisM Subramanian, P Francis, S Bilke, et al.
Pediatric Research|August 29, 2000
Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinctC Busquets, B Merinero, E Christensen, et al.
Molecular Genetics and Metabolism|January 9, 2010
Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case seriesM Pineda, M S Perez-Poyato, M O'Callaghan, et al.
JACC. Basic to Translational Science|January 31, 2020
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 StudyFrancesco Franchi, Fabiana Rollini, Victor Kairouz, et al.
Journal of the American Heart Association|April 21, 2020
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y<sub>12</sub> Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC StudyFrancesco Franchi, Fabiana Rollini, Gabriel Faz, et al.
Lancet (London, England)|April 2, 2025
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trialAjay J Kirtane, Philippe Généreux, Bruce Lewis, et al.
JACC. Cardiovascular Interventions|March 29, 2023
Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart FailureBenjamin Hibbert, Firas Zahr, Trevor Simard, et al.
Pageof 40

Showing results (371-380 of 395) with videos related to

Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Safety and dose modification for patients receiving niraparibJ S Berek, U A Matulonis, U Peen, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Oncogene|March 26, 2014
A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasisM Subramanian, P Francis, S Bilke, et al.
Pediatric Research|August 29, 2000
Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinctC Busquets, B Merinero, E Christensen, et al.
Molecular Genetics and Metabolism|January 9, 2010
Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case seriesM Pineda, M S Perez-Poyato, M O'Callaghan, et al.
JACC. Basic to Translational Science|January 31, 2020
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 StudyFrancesco Franchi, Fabiana Rollini, Victor Kairouz, et al.
Journal of the American Heart Association|April 21, 2020
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y<sub>12</sub> Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC StudyFrancesco Franchi, Fabiana Rollini, Gabriel Faz, et al.
Lancet (London, England)|April 2, 2025
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trialAjay J Kirtane, Philippe Généreux, Bruce Lewis, et al.
JACC. Cardiovascular Interventions|March 29, 2023
Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart FailureBenjamin Hibbert, Firas Zahr, Trevor Simard, et al.
Pageof 40